Ernie, I apologize if I came off as testy, it was not directed at you, that I assure you. Just distinguising hype for enthusiasm, and pointing out that FTEL was a speculation, not a foregone conclusion, as are most micro-caps.
The difference is FTEL is based on a solid infrastructure, proprietary technologies, and a skilled leader. Manyt OTC-BB stocks, especially those that are non-reporting companies, are pipe dreams, built on hot air, and claims of grandeur, yet the CEO has the management skills, exkperience, knowledge, or integrity of a shoe. That's when a balance sheet is important, to sort out the true viability or to give proof of all the claims.
There are several companies in the micro-cap arena that do in fact report, but due to obscurity, are undiscovered by the street. An example of one is OPMC, with back to back qtrs. .05 EPS and .07 EPS and yet the stock price is about $1.50 per share. They are like a finding a blue chip amongst buffalo chips,a truegrowth company, with supporting fundamentals, just undiscovered.
Like all things, due dilly combined with a small knowledge of an industry, can help in discovering some of the gems, and also help you avoid the snake oil salesman.
RB |
